Chunying Zhuang

ORCID: 0000-0002-2602-0160
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular Function and Risk Factors
  • Advanced Glycation End Products research
  • Neuroscience of respiration and sleep
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Obstructive Sleep Apnea Research
  • Histone Deacetylase Inhibitors Research
  • Cardiac Ischemia and Reperfusion
  • Natural Antidiabetic Agents Studies
  • Vascular Anomalies and Treatments
  • Heart Rate Variability and Autonomic Control
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cardiovascular and exercise physiology
  • Congenital Heart Disease Studies
  • Cystic Fibrosis Research Advances
  • Circadian rhythm and melatonin
  • Immune Response and Inflammation
  • Asthma and respiratory diseases
  • Cardiac Arrhythmias and Treatments
  • Inflammasome and immune disorders
  • Mangiferin and Mango Extracts
  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research

Guangzhou Medical University
2021-2023

First Affiliated Hospital of Guangzhou Medical University
2021-2023

Sichuan University
2023

State Key Laboratory of Respiratory Disease
2021-2023

Fuzhou University
2023

National Clinical Research Center for Digestive Diseases
2021

The aetiological composition and clinical characteristics of patients with pulmonary hypertension (PH) hospitalised in the respiratory department were retrospectively analysed, as well correlation between transthoracic echocardiography (TTE) right heart catheterization (RHC) for evaluating artery systolic pressure (PASP) mean (mPAP).Of 731 patients, 544 (74.42%) diagnosed PH by RHC. Pulmonary arterial (PAH) was most common type PH, accounting 30.10%; due to lung disease and/or hypoxia...

10.1111/crj.13623 article EN cc-by The Clinical Respiratory Journal 2023-05-04

Tucidinostat, which is a subtype-selective histone deacetylase inhibitor, has been approved in China for the treatment of hormone receptor-positive (HR

10.21037/atm-23-1913 article EN Annals of Translational Medicine 2023-12-01

To evaluate the safety and efficacy of bilateral balloon pulmonary angioplasty (BPA) as compared with unilateral BPA for patients inoperable chronic thromboembolic hypertension (CTEPH).We reviewed 210 consecutive sessions 92 CTEPH patients, including 124 86 sessions. Radiation exposure, operation details, lesions characteristics occurrence complications were between BPA. 131 a hemodynamics follow-up included analysis, in which changes compared. Logistic regression analysis was used to...

10.1186/s12931-022-02017-6 article EN cc-by Respiratory Research 2022-05-07
Coming Soon ...